Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dahlqvist

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
European Journal of Clinical Pharmacology|July 25, 2000
Co-ordinating editor's comments on the letter to the editors by A. HerxheimerR Dahlqvist
Praxis Und Klinik Der Pneumologie|October 1, 1983
Theophylline--plasma concentration related to bronchodilatation and side effectsR Dahlqvist
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1983
Pharmacokinetic properties of a new sustained-release theophylline preparationR Dahlqvist, B Billing
Scandinavian Journal of Rheumatology|April 24, 2013
Comparison of the 1987 ACR and 2010 ACR/EULAR classification criteria for rheumatoid arthritis in clinical practice: a prospective cohort studyE Berglin, S R Dahlqvist
British Journal of Rheumatology|September 1, 1993
Interference with the cortisol axis by the microtubule antagonist, CPH82S R Dahlqvist, T Olsson
Human Heredity|January 1, 1985
Haptoglobin groups and rheumatoid arthritisS R Dahlqvist, N Fröhlander
British Journal of Clinical Pharmacology|February 1, 1981
Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interactionK Schenck-Gustafsson, R Dahlqvist
European Journal of Respiratory Diseases. Supplement|January 1, 1984
Theophylline--clinical pharmacokinetics and therapeutic drug monitoringR Dahlqvist, B Billing, E Ripe
British Journal of Clinical Pharmacology|March 22, 2001
Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteersS Hägg, O Spigset, R Dahlqvist
Drug Safety|July 6, 2000
HMG-CoA reductase inhibitors and myotoxicityM Ucar, T Mjörndal, R Dahlqvist
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
European Journal of Clinical Pharmacology|July 25, 2000
Co-ordinating editor's comments on the letter to the editors by A. HerxheimerR Dahlqvist
Praxis Und Klinik Der Pneumologie|October 1, 1983
Theophylline--plasma concentration related to bronchodilatation and side effectsR Dahlqvist
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1983
Pharmacokinetic properties of a new sustained-release theophylline preparationR Dahlqvist, B Billing
Scandinavian Journal of Rheumatology|April 24, 2013
Comparison of the 1987 ACR and 2010 ACR/EULAR classification criteria for rheumatoid arthritis in clinical practice: a prospective cohort studyE Berglin, S R Dahlqvist
British Journal of Rheumatology|September 1, 1993
Interference with the cortisol axis by the microtubule antagonist, CPH82S R Dahlqvist, T Olsson
Human Heredity|January 1, 1985
Haptoglobin groups and rheumatoid arthritisS R Dahlqvist, N Fröhlander
British Journal of Clinical Pharmacology|February 1, 1981
Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interactionK Schenck-Gustafsson, R Dahlqvist
European Journal of Respiratory Diseases. Supplement|January 1, 1984
Theophylline--clinical pharmacokinetics and therapeutic drug monitoringR Dahlqvist, B Billing, E Ripe
British Journal of Clinical Pharmacology|March 22, 2001
Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteersS Hägg, O Spigset, R Dahlqvist
Drug Safety|July 6, 2000
HMG-CoA reductase inhibitors and myotoxicityM Ucar, T Mjörndal, R Dahlqvist
Pageof 11